The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma

Circulating tumor cells (CTCs) are a promising biomarker for several cancers. We streamlined the experimental procedure of CTC immunofluorescent staining. We encountered a 72-year-old woman with metastatic right renal cell carcinoma (RCC) (clinical stage: T4N0M1), whose CTC number rapidly increased...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagaya, Naoya, Kanayama, Mayuko, Nagata, Masayoshi, Horie, Shigeo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191600/
https://www.ncbi.nlm.nih.gov/pubmed/29709937
http://dx.doi.org/10.2169/internalmedicine.0663-17

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6191600/
https://www.ncbi.nlm.nih.gov/pubmed/29709937
http://dx.doi.org/10.2169/internalmedicine.0663-17

Ejemplares similares